AFP — AFT Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- AU$310.68m
- AU$342.61m
- NZ$156.64m
- 87
- 22
- 42
- 51
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.92 | 6.12 | 3.21 | 7.94 | 4.75 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 16.3 | 22.6 | 29.2 | 29.9 | 39.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 51.3 | 55.3 | 67.9 | 77.5 | 94.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.357 | 4.03 | 3.79 | 3.36 | 3.37 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 63.6 | 87.1 | 105 | 127 | 148 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58.5 | 25.1 | 32.1 | 29.1 | 39.8 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 58.5 | 69.8 | 68.5 | 65 | 74.8 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.09 | 17.3 | 36.6 | 62.3 | 73.3 |
Total Liabilities & Shareholders' Equity | 63.6 | 87.1 | 105 | 127 | 148 |
Total Common Shares Outstanding |